France Live Biotherapeutic Products And Microbiome Cdmo Market Size & Outlook
France live biotherapeutic products and microbiome cdmo market, 2018-2030 (US$M)
Related Markets
France live biotherapeutic products and microbiome cdmo market highlights
- The France live biotherapeutic products and microbiome cdmo market generated a revenue of USD 0.7 million in 2023 and is expected to reach USD 11.0 million by 2030.
- The France market is expected to grow at a CAGR of 48.4% from 2024 to 2030.
- In terms of segment, c.difficle was the largest revenue generating application in 2023.
- C.difficle is the most lucrative application segment registering the fastest growth during the forecast period.
Live biotherapeutic products and microbiome cdmo market data book summary
| Market revenue in 2023 | USD 0.7 million |
| Market revenue in 2030 | USD 11.0 million |
| Growth rate | 48.4% (CAGR from 2023 to 2030) |
| Largest segment | C.difficle |
| Fastest growing segment | C.difficle |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | C.difficle, Crohns disease, IBS, Diabetes |
| Key market players worldwide | Carbios SA, Boise Cascade Co, Assembly Biosciences Inc, Wacker Chemie AG, SGS AG, Lonza Group Ltd, Arranta Bio, 4D Pharma, NIZO, Inpac Pharma |
Other key industry trends
- In terms of revenue, France accounted for 2.2% of the global live biotherapeutic products and microbiome cdmo market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany live biotherapeutic products and microbiome cdmo market is projected to lead the regional market in terms of revenue in 2030.
- France is the fastest growing regional market in Europe and is projected to reach USD 11.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Live Biotherapeutic Products And Microbiome CDMO Market Scope
Live Biotherapeutic Products And Microbiome CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France live biotherapeutic products and microbiome cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to live biotherapeutic products and microbiome cdmo market will help companies and investors design strategic landscapes.
C.difficle was the largest segment with a revenue share of 85.71% in 2023. Horizon Databook has segmented the France live biotherapeutic products and microbiome cdmo market based on c.difficle, crohns disease, ibs, diabetes covering the revenue growth of each sub-segment from 2018 to 2030.
The pharmaceutical industry in France is a technology-driven, innovative, and densely populated industry with high levels of technological & logistical expertise. The biopharmaceutical services industry in the country has benefited from the recent trends in the biopharmaceutical landscape, as many manufacturers have divested their clinical research, development, and manufacturing with new technology & manufacturing facilities.
For instance, in July 2023, Exeliom Biosciences, a clinical-stage biopharmaceutical company, announced a USD 26.30 million Series A funding to advance the clinical development of its therapeutic pipeline, which includes several clinical trials of EXL01. EXL01 is a novel immunotherapy with applications in infectious diseases and cancer. An increase in investment is a key strategy implemented by the market to gain a competitive edge for generating future revenue.
Reasons to subscribe to France live biotherapeutic products and microbiome cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France live biotherapeutic products and microbiome cdmo market databook
-
Our clientele includes a mix of live biotherapeutic products and microbiome cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France live biotherapeutic products and microbiome cdmo market , including forecasts for subscribers. This country databook contains high-level insights into France live biotherapeutic products and microbiome cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
France live biotherapeutic products and microbiome cdmo market size, by application, 2018-2030 (US$M)
France Live Biotherapeutic Products And Microbiome CDMO Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
